Nature Biotechnology 2003 Jeffrey L Fox - Abstracts

Nature Biotechnology 2003 Jeffrey L Fox
TitleSubjectAuthors
FDA embraces risk-management approach.BusinessJeffrey L. Fox
FDA panel recommends easing gene therapy trial limits.(Food and Drug Administration)BusinessJeffrey L. Fox
US bioethics committee weighs in.BusinessJeffrey L. Fox
US bioterrorism countermeasures research builds across a broad front.BusinessJeffrey L. Fox
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.